The use of vaccinations for rabbits from myxomatosis and HBV
Complex vaccinations for rabbits from myxomatosis and HBV are an effective means of preserving the livestock from death.
Vaccine for rabbits from myxomatosis and HBV
Pharmacology Associated Vaccination
Associated vaccine for myxomatosis and rabbit viral hemorrhagic disease is available in one of two possible strains:
- B82 rabbit myxomatous viral pathogen,
- B87 viral causative agent of rabbit hemorrhagic infection.
Outwardly, it looks like a dry porous mixture, the color shade of which varies from light pink to light brown.
Live vaccine for rabbits from myxomatosis and HBVC is packaged in sterile sealed ampoule containers with a volume of 0.5-2 ml of active substance or in glass sealed bottles with a volume of 4-6 ml of active substance.
When purchasing a dry vaccine against myxomatosis and HBV, special attention should be paid to the presence of a label with the name of the manufacturer, series and control titles, packaging date, quantitative data on the contained doses and expiration dates.
The quantitative indicator of the contained immunizing doses depends on the release form in the vaccine container against myxomatosis and rabbit viral hemorrhagic disease and can range from 5 to 120.
The live dry vaccine can be used intramuscularly, subcutaneously or intradermally, causing sustained resistance from the third day after inoculation, actively acting throughout the calendar year.
Action Nobivak Mixo
Nobivak vaccine against myxomatosis and HBVC is a set of a dry, lyophilized mixture of a light pink hue with the supplied solvent for the manufacture of an injection solution in a vial. It is made from a cell line that is infected with a myxomatous viral infection with constructed rabbit GB coding genes. In addition to viral strains, the composition of the drug includes:
- stabilizers, including 25 mg of sorbitol, 12.5 mg of gelatin hydrolyzate, 12.5 mg of casein hydrolyzate,
- sodium dihydrate - 0.065 mg.
The sterile phosphate-buffer diluent included in the vaccination kit, according to the instructions, is a mixture of sodium dihydrate (0.31 mg), potassium dihydrogen phosphate (0.21 mg) and water (1 ml).
When dissolved, Nobivak Mixo does not precipitate or flakes, it dissolves well in a homogeneous transparent liquid.
The release of Nobivak Mixo is organized in 1 or 50 immunizing doses in glass or plastic, packaged in 5-10 pieces.
When Nobivac Myxo is vaccinated, immunity against the effects of viral infections of myxomatosis and HBV is formed after a three-week period, ensuring the action of the active substance throughout the calendar year.
Pharmacology Lapimun Gemiks
Ukrainian vaccine against myxomatosis of rabbits and from HBV Lapimun Gemiks refers to a medicine that includes two main components:
- the inactivated pathogen source of the viral hemorrhagic infection of rabbits is presented in the form of a suspension with strain BG04, which serves as a solvent,
- myxomatous virus carrier is presented as a lyophilisate of strain MAV RK-13 \ 20.
Lapimun medication is placed in a 10 ml vlakon, which makes immunizing 50 doses.
The vaccine develops stable resistance from 1-2 weeks after injection and remains active for up to 10 months.
Resistance of rabbits to hemorrhagic infections and myxomatosis is developed no later than two weeks after vaccination with Lapimuna Gemiks.
Among the contraindications for the use of the medicinal drug in the instructions are warnings: when using the drug for rabbits, vaccination is avoided a week before the round-up in order to avoid stress conditions in rabbits and related mechanical abortions.
Depending on the type of vaccine that rabbits are vaccinated against myxomatosis and HBV, their dosage is set by the instructions for the drug.
Live Associated Vaccination
The vaccine for rabbits from myxomatosis and HBVC associated is applicable for the purpose of prevention among healthy individuals. Moreover, in regions favorable for infections, vaccination occurs once, from a month and a half age of rabbits. In unfavorable areas where quarantine measures for myxomatosis and HBV are imposed, rabbits are vaccinated, followed by revaccination of young individuals three months after the initial vaccination.
The dosage order of the drug depends on the injection method:
- for the purpose of intramuscular and subcutaneous injection, the dry mixture is diluted in a proportion of 1 dosage of 0.5 ml of the solution, and the finished prepared vaccine in a volume of 0.5 ml is administered in the thigh area,
- for the purpose of intradermal administration of the drug, 1 dose of the drug is diluted with 0.2 ml of the solution and the finished vaccine with a volume of 0.2 ml is administered in the auricle or in the area of the undermine.
When using the associated vaccine, revaccination is recommended after 9 months.
Nobivac vaccines rabbits for myxomatosis and HBV. Pets by the time of the procedure should reach the age of 5 weeks, decorative dwarf breeds are also vaccinated. The vaccine from the disease must be diluted in a ratio of 1: 1, vaccinated 1 ml subcutaneously. To prevent the crawl from getting sick, the drug should be revaccinated at least once a calendar year.
Live vaccine for rabbits Lapimun hemix in the form of a prophylactic against the disease is suitable for rabbits of the age category of 10 weeks. It is administered once in regions with a favorable epidemiological situation from the age of 10 weeks with the existing threat of infection, followed by revaccination after reaching the age of 4 months. By the time of the first vaccination, the animal must gain a weight of at least 0.5 kg. At lower rates, the vaccine for rabbits from myxomatosis and HBV is delayed, it is done when the necessary mass is gained. For a single vaccination of rabbits from myxomatosis and HBVC, the dosage is 1.0 ml of the active substance obtained by mixing the suspension and lyophilisate.
The route of injection is subcutaneously in the area behind the scapula. The Lapimun Hemix vaccine is repeated after 8 months.
When conducting vaccination activities, it is necessary to follow the scheme, vaccination is carried out on time, since violation of the vaccination calendar often leads to a decrease in the effectiveness of the drug in the prevention of the disease. Before vaccinating rabbits, for 2 weeks all animals are subject to mandatory deworming. Conducting deworming measures is also possible 2 weeks after the injection of one of the above drugs.
Side effects and special instructions
After vaccination, the animal is observed for at least 20 days.
Moreover, as possible and permissible consequences, one can observe:
- small increases in lymph nodes that pass after 3 days,
- some swelling at the injection site, which disappears after a 1-2-week period.
There were no adverse side effects and any complications when using the vaccine against myxomatosis and HBV in rabbits. It should be borne in mind that they should not appear in conditions of compliance with the recommendations set forth in the instructions for vaccine-containing drugs.
Symptomatic measures are sometimes required for those individuals who are prone to hypersensitivity.
Containers with dry vaccine for rabbits for myxomatosis and HBV with a past date of suitability and without labeling are not used. The same applies to the color-changing mixtures, liquids with interspersed impurities, drugs not used after 3-4 hours after opening.
During the injection process, the rules of personal hygiene provided for working with medicines are observed.
According to general rules, the shelf life of the active drug for vaccination is 2 years, the solvent can be stored for 4 years in glass and 2 years in plastic. Medicines are stored in dry places with a temperature of 2-25 ° C, sunlight should not enter the storage rooms. Another point is to follow the instructions for the vaccine against myxomatosis and HBV in rabbits, without which it is impossible to succeed and prevent the disease. And in any case, before vaccinating the animal, you need to consult a veterinarian, or even entrust him with such an important matter.